Skip to main content
Get Alerts

FDA Drug Recalls

Every FDA drug enforcement recall Public Health Trace has on record, republished from openFDA's official drug enforcement database. See Health Alerts for current, active recalls alongside outbreaks and advisories.

Drug recall information is sourced from the FDA's structured openFDA Enforcement Reports. Newly announced recalls may appear on FDA.gov before they become available in the structured dataset. See Methodology for how Public Health Trace imports and refreshes this data.

Filters
Recall details
Location
Date range
Clear filters

Showing 7,501–7,520 of 17,964 drug recalls

Drug Recall Terminated Historical recordClass II

Awake, 500 mg Capsules, 90-count bottles, Distributed by Herbal Doctor Remedies Alhambra, CA 91801-7081 USA, 1(800) 600-0808

by Herbal Doctor Remedies

Reason
CGMP Deviations: Products were manufactured outside of the controls required by current Good Manufacturing Practices.
Recall initiated
July 12, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide within the United States and Brazil and on the internet

View recall →

Drug Recall Terminated Historical recordClass II

Mometasone Furoate Cream USP, 0.1%, packaged in a) 15gram tubes (NDC 68462-192-17) and b) 45 gram tubes (NDC 68462-192-55), Rx Only, Manufactured by; Glenmark Pharmaceuticals Ltd At: Village: Kishanpura, Baddi Nalagari Road, District: Solan, Himachal Pradesh -173205, India Glenmark Pharmaceuticals Inc., USA Mahwah, NJ 07430

by Glenmark Pharmaceuticals Inc., USA

Reason
GMP Deviations: Glenmark received complaints stating that mometasone fuorate cream was gritty.
Recall initiated
July 23, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide within the United States

View recall →

Drug Recall Terminated Historical recordClass II

ZINC SULFATE 1MG/ML INJECTION SOLUTION, 30ML per VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0152-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

ZINC SULFATE 1MG/ML INJECTION SOLUTION (PFV), 10ML per VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0963-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

VITAMIN B COMPLEX 100 (MDV), 30 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0976-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

TURBO DROPS (PHEN 2.5% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0205-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

TURBO DROPS (PHEN 10% / CYCLO 1%/ TROP 1%/ KETO 0.5%) OPHTH SOLN, 5 ML per dropper bottle, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0206-05

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

TURBO DROPS (PHEN 0.625%/CYCLO 0.25%/TROP 0.25%/KETO 0.125%) OPHTH SOLN, 0.4 ML per Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0192-81

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

TURBO CAINE 2.5 (PHEN2.5/CYCLO1/ TROP1/TETRA 0.5), 0.4 ML per Syringe, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0193-81

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

TRAVASOL 10% (AMINO ACID) INJECTION SOLUTION, 50 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0151-50

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

THIAMINE HCL 100MG/ML (MDV) INJECTION, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0950-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

TAURINE 50 MG/ML (MDV) INJECTABLE, 30 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0958-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

SUCCINYLCHOLINE CHLORIDE 20MG/ML INJ SOL, 10 ML per Vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC 70731-0129-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

SOD-PHOS (PHOS 3MMOL/ML-SOD 4MEQ/ML) PFV INJ SOLN, 10 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0905-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

SODIUM BICARBONATE 8.4% (1 MEQ/ML) INJ SOLN (PFV), 50 ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0957-50

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

RIBOFLAVIN 0.1% OPHTHALMIC SOLUTION SYRINGE, 2 ML per syringe. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0923-02

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

PYRIDOXINE (PFV) 100MG/ML, 30ML PER VIAL. RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0955-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

PYRIDOXINE (MDV) 100MG/ML, 30ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0956-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

PROCAINE HCL 8% (PFV) INJECTABLE, 10ML PER VIAL, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0970-10

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Drug Recall Terminated Historical recordClass II

PROCAINE HCL (PFV) 20 MG/ML INJECTABLE SOLUTION, 30 ML per vial, RXQ Compounding, 340 West State Street, Unit 9, Athens, OH 45701. NDC: 70731-0900-30

by RXQ Compounding LLC

Reason
Lack of Assurance of Sterility
Recall initiated
June 19, 2019
Reported by FDA
August 14, 2019
Distribution
Nationwide USA

View recall →

Data last updated:

This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice -- always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take. Read the full medical disclaimer.